OneMedNet Corporation (ONMD)
NASDAQ: ONMD · Real-Time Price · USD
0.5800
-0.0051 (-0.87%)
Aug 28, 2026, 4:00 PM EDT - Market closed
OneMedNet Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.46 | 1.36 | 0.64 | 1.02 | 1.15 | 1.09 | |
Revenue Growth | 216.99% | 111.35% | -37.02% | -11.43% | 5.58% | 32.49% |
Cost of Revenue | 2.67 | 1.86 | 0.92 | 1.15 | 1.51 | 1.21 |
Gross Profit | -1.21 | -0.5 | -0.28 | -0.13 | -0.36 | -0.11 |
Selling, General & Admin | 7.52 | 7.65 | 7.86 | 4.66 | 10.11 | 1.95 |
Research & Development | 1.4 | 1.52 | 1.47 | 2.07 | 0.95 | 0.64 |
Operating Expenses | 8.92 | 9.16 | 9.32 | 6.72 | 11.06 | 2.6 |
Operating Income | -10.13 | -9.67 | -9.61 | -6.85 | -11.43 | -2.71 |
Interest Expense | -0.03 | -0.07 | -0.15 | -0.01 | -0.4 | -0.2 |
Other Non Operating Income (Expenses) | -0.16 | 1.41 | -0.38 | -26.9 | 4.44 | -0.03 |
EBT Excluding Unusual Items | -10.33 | -8.33 | -10.13 | -33.76 | -7.39 | -2.94 |
Gain (Loss) on Sale of Investments | - | - | - | - | 1.37 | - |
Other Unusual Items | 1.82 | 5.53 | - | - | - | - |
Pretax Income | -8.51 | -2.8 | -10.13 | -33.76 | -6.01 | -2.94 |
Income Tax Expense | 0 | 0 | 0 | 0.02 | 0.21 | - |
Net Income | -8.51 | -2.8 | -10.13 | -33.78 | -6.23 | -2.94 |
Net Income to Common | -8.43 | -2.8 | -10.13 | -33.78 | -6.23 | -2.94 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 55 | 45 | 28 | 7 | 5 | 4 |
Shares Outstanding (Diluted) | 55 | 45 | 28 | 7 | 5 | 4 |
Shares Change | 65.60% | 58.67% | 286.14% | 59.46% | 5.44% | - |
EPS (Basic) | -0.15 | -0.06 | -0.36 | -4.65 | -1.37 | -0.68 |
EPS (Diluted) | -0.15 | -0.06 | -0.36 | -4.65 | -1.37 | -0.68 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.89 | -7.52 | -7 | -4.84 | 87.18 | -1.87 |
Free Cash Flow Per Share | -0.13 | -0.17 | -0.25 | -0.67 | 19.12 | -0.43 |
Gross Margin | -83.30% | -37.01% | -43.70% | -12.63% | -31.29% | -10.39% |
Operating Margin | -696.15% | -711.33% | -1493.78% | -671.20% | -991.16% | -248.27% |
Profit Margin | -579.11% | -206.11% | -1575.27% | -3308.52% | -540.42% | -269.37% |
Free Cash Flow Margin | -473.75% | -553.05% | -1089.11% | -473.56% | 7562.99% | -171.68% |
EBITDA | -10.09 | -9.6 | -9.55 | -6.83 | -11.4 | -2.7 |
EBITDA Margin | - | - | - | - | - | -246.95% |
D&A For EBITDA | 0.04 | 0.07 | 0.06 | 0.03 | 0.02 | 0.01 |
EBIT | -10.13 | -9.67 | -9.61 | -6.85 | -11.43 | -2.71 |
EBIT Margin | - | - | - | - | - | -248.27% |
Revenue as Reported | 1.46 | 1.36 | 0.64 | 1.02 | - | - |